Goldman Sachs Downgrades CME Group (CME) to Sell on EPS Risk and Valuation
Tweet Send to a Friend
Goldman Sachs downgraded CME Group (NASDAQ: CME) from Neutral to Sell with a price target of $48.00 (from $53.00) saying ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
